PBMs, Policy, and the Human Cost of Delay in Metabolic Care
Administrative barriers and benefit design delays in metabolic care restrict access to GLP-1 and incretin therapies, worsening diabetes and obesity outcomes while widening equity gaps.
The skinny
The skinny isn't ready yet — notes appear once the transcript is processed.